Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVE: Infliximab in ANCA Associated Vasculitis
NCT00753103Phase 2Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Jan 2003
- Primary completion
- Jul 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by University Hospitals Birmingham. Started Jan 2003; status: completed.
02
Drugs
infliximab
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT00753103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753103.